Anthony Fletcher, Graze CEO, discusses how his startup company is changing the way consumers eat by offering portion-controlled snacks tailored to suit individual tastes.» Read More
Anne Mulcahy, former Xerox chairman & CEO, shares her thoughts on the ousting of Best Buy CEO Brian Dunn.
Stephen Stagner, CEO of Mattress Firm, and Anne Mulcahy, former Xerox chairman & CEO, discuss Mattress Firm's IPO and record earnings results from earlier this week.
Economists will pick apart today's CPI report for the bottom-line on inflation. Cliff Hudson, Sonic Chairman & CEO, offers the story on price pressures from the front-line. Sonic is the country's largest chain of drive-in restaurants.
Colin Angle, iRobot Corp. CEO, discusses recent advances in "app ready" robot services for health care, retail, and the security industry. Also, the outlook for domestic and international growth, with the Fast Money traders.
Investors are suddenly hot for biotechnology, and that helps Celgene, CEO Robert Hugin told CNBC Thursday.
Sanofi CEO Christopher Viehbacher discusses his company's $20 billion acquisition of Genzyme and other opportunities he sees in the pharmaceutical market.
The S&P Biotech Index is up more than 10 percent and Celgene is one of its biggest gainers. Robert Hugin, Celgene chairman & CEO, discusses what's driving the company's growth, including its recent acquisition of Avila Therapeutics.
Frank Blake, Home Depot chairman & CEO, explains why a stronger housing recovery will help his business.
Sharing perspective on whether stellar auto sales in March can continue, with Gary Flom, Manhattan Automobile president & CEO; Jessica Caldwell, Edmunds.com senior analyst; and CNBC's Phil LeBeau.
Terry Lundgren, Macy's chairman, president & CEO, offers insight into retail trends and his company's business strategy. He also comments on the challenges faced by Ron Johnson, CEO of J.C. Penney.
Eli Lilly hopes one of its dyes, used to determine whether someone may have Alzheimer's disease, will counter the expected lost income loss income from losing patents on some of its best-selling drugs, the CEO said on CNBC Thursday.
Home Depot had a strong fourth quarter, thanks to unusually mild winter weather, CEO Frank Blake told CNBC Thursday, but that same mild weather is making it unclear just how strong the U.S. economic recovery really is.
Retail giants from around the world are gathered at a global retailing conference in Arizona. CNBC's Michelle Caruso-Cabrera spoke with Frank Blake, Home Depot chairman & CEO.
Insight on Eli Lilly's pipeline and how it's likely to boost profits, with John Lechleiter, Eli Lilly CEO.
Cantor Fitzgerald expands its emerging markets business. Shawn Matthews, Cantor Fitzgerald CEO, offers insight.
Jim Chanos, Kynikos Associates founder & CEO, says valuation is the least important determinant when looking for ideas on the short side. "We're looking for flawed businesses; we're looking for flawed accounting [and] technological changes," he says.
It's been nearly two years since George Scangos took the helm of Biogen. The stock recently hit a new high. George Scangos, Biogen CEO, discusses the company's lineup for 2015.
Jim Chanos, Kynikos Associates founder & CEO, offers insight on China's economy. "I think they're still trying desperately to cool the property sector," he says.
Jeremy Allaire, Brightcove founder, chairman & CEO, offers insight on the company's IPO in February.
A report out today finds members of the trade group PhRMA invested $49.5 billion in research and development last year. John Castellani, PhRMA President & CEO, weighs in.